康泰医学
(300869)
| 流通市值：35.32亿 | | | 总市值：56.01亿 |
| 流通股本：2.53亿 | | | 总股本：4.02亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 747,382,470.78 | 684,307,771.48 | 602,394,001.29 | 508,766,739.38 |
| 应收票据及应收账款 | 45,683,043.03 | 45,998,781.84 | 42,185,451.66 | 42,836,340.49 |
| 应收账款 | 45,683,043.03 | 45,998,781.84 | 42,185,451.66 | 42,836,340.49 |
| 预付款项 | 9,570,191.8 | 6,178,488.89 | 8,585,704.82 | 9,814,110.85 |
| 其他应收款合计 | 13,127,983.6 | 7,341,827.52 | 15,408,410.61 | 18,688,923.47 |
| 存货 | 265,882,645.56 | 272,322,956.49 | 404,174,990.72 | 430,089,319.66 |
| 一年内到期的非流动资产 | 359,453,347.21 | 252,028,342.47 | 163,935,069.48 | 162,664,861.14 |
| 其他流动资产 | 31,339,708.67 | 481,453,009 | 4,135,867.61 | 4,798,007.21 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,144,746,579.76 | 1,921,219,260.88 | 1,851,736,075.88 | 1,869,207,101.02 |
| 非流动资产: | | | | |
| 投资性房地产 | 6,555,703.44 | 8,265,877.77 | 14,402,512.19 | 16,792,694.31 |
| 固定资产 | 256,421,051 | 259,352,784.07 | 255,036,030.88 | 256,325,513.65 |
| 在建工程 | 73,556,675.43 | 72,847,298.84 | 54,639,534.76 | 42,310,556.8 |
| 使用权资产 | 3,377,867.15 | 3,867,651.58 | 4,231,778.53 | 4,727,420.14 |
| 无形资产 | 51,402,129.11 | 52,073,505.19 | 52,755,856.42 | 53,385,110.3 |
| 长期待摊费用 | 67,385.13 | 70,526.01 | 175,894.62 | - |
| 递延所得税资产 | 4,950,838.72 | 3,779,708.93 | 9,571,964.24 | 7,902,953.7 |
| 其他非流动资产 | 246,326,937.39 | 404,040,573.76 | 590,043,575.02 | 584,175,244.46 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 642,658,587.37 | 804,297,926.15 | 980,857,146.66 | 965,619,493.36 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,787,405,167.13 | 2,725,517,187.03 | 2,832,593,222.54 | 2,834,826,594.38 |
| 流动负债: | | | | |
| 短期借款 | 91,436,896.37 | 60,000,000 | 90,000,000 | 90,000,000 |
| 应付票据及应付账款 | 14,451,777.63 | 18,393,772.57 | 15,555,862.78 | 19,031,518.26 |
| 应付账款 | 14,451,777.63 | 18,393,772.57 | 15,555,862.78 | 19,031,518.26 |
| 合同负债 | 42,556,014.33 | 32,036,930.34 | 36,440,198.91 | 43,614,953.1 |
| 应付职工薪酬 | 11,410,781.34 | 11,304,868.91 | 14,784,527.9 | 11,825,698.42 |
| 应交税费 | 5,899,560.77 | 1,528,862.75 | 8,643,580.67 | 6,205,420.69 |
| 其他应付款合计 | 5,312,203.14 | 10,105,860.34 | 6,533,174.09 | 6,977,041.88 |
| 一年内到期的非流动负债 | 1,312,021.13 | 1,418,205.79 | 1,477,447.32 | 1,803,081.98 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 172,379,254.71 | 134,788,500.7 | 173,434,791.67 | 179,457,714.33 |
| 非流动负债: | | | | |
| 应付债券 | 731,806,196.59 | 723,521,709.93 | 715,132,644.65 | 711,709,367.87 |
| 租赁负债 | 1,486,762 | 1,834,700.4 | 2,549,007.42 | 2,781,067.02 |
| 递延收益 | 7,605,487.13 | 7,810,033.22 | 8,029,163.72 | 8,373,503.71 |
| 递延所得税负债 | 137,351.75 | 146,492.86 | - | 284.67 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 741,035,797.47 | 733,312,936.41 | 725,710,815.79 | 722,864,223.27 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 913,415,052.18 | 868,101,437.11 | 899,145,607.46 | 902,321,937.6 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 401,802,977 | 401,802,977 | 401,802,765 | 401,802,765 |
| 其他权益工具 | 29,613,936.75 | 29,613,936.75 | 29,614,253.01 | 29,614,253.01 |
| 资本公积 | 352,340,023.82 | 352,340,023.82 | 345,146,203.51 | 345,146,203.51 |
| 其他综合收益 | 3,464,836.66 | 3,326,239.41 | 2,215,756.14 | 3,008,604.91 |
| 专项储备 | 3,469,428.06 | 3,469,428.06 | - | - |
| 盈余公积 | 174,456,618.55 | 174,456,618.55 | 174,456,618.55 | 174,456,618.55 |
| 未分配利润 | 908,842,294.11 | 892,406,526.33 | 980,212,018.87 | 978,476,211.8 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,873,990,114.95 | 1,857,415,749.92 | 1,933,447,615.08 | 1,932,504,656.78 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,873,990,114.95 | 1,857,415,749.92 | 1,933,447,615.08 | 1,932,504,656.78 |
| 负债和股东权益合计 | 2,787,405,167.13 | 2,725,517,187.03 | 2,832,593,222.54 | 2,834,826,594.38 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-28 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |